REGULATORY TECHNICALITIES FOR DRUG PRODUCT REGISTRATION IN BRAZIL
Journal Title: International Journal of Drug Regulatory Affairs - Year 2017, Vol 5, Issue 4
Abstract
Brazilians are demanding better healthcare and modern medicines, presenting significant opportunities for foreign investment. In Brazil, medicinal product registration is an extensive process. To do business in Brazil is not without its challenges. Accessing the Brazilian healthcare market can be a major headache for many medium and small companies without the resources and market knowledge to handle this highly regulated, technical, fragmented and sometimes corrupt process. The Active Pharmaceutical Ingredient and excipients should be informed with their DCB (Common Brazilian Denomination) number and administration, specifications, leaflets/labels, precautions, and relevant information regarding the drug products must be submitted in Portuguese language in a dossier. The registration process for medicine takes more than a year. In Latin America, Brazil, Argentina, and Chile are countries which provide encouragement for generic product registration by discounting the registration fees for generics. Regardless of the challenges and qualms, Brazil’s diverse population of nearly 200 million people, their geographic location in America Latina and off course its emerging economy have proven to be enticing and promising as a profitable market for many drug makers.
Authors and Affiliations
Charmy Kothari, Shah Manan, Mohak Vaishnav
Keywords
Related Articles
- EP ID EP329079
- DOI 10.22270/ijdra.v5i4.206
- Views 223
- Downloads 0
Regulatory requirements for preparation of Dossier for registration of Pharmaceutical products in ACTD & CTD format
To prepare and compile the Dossier required for Registration of Pharmaceutical Products as per the requirements of each countries which shall be acceptable internationally to develop one regulatory approach. To avoid var...
Regulatory aspects for Biologic product licensing in India
Biologics are the medicinal/ therapeutic/ diagnostic/ preventive preparations composed or derived from living organisms and their spin-off for human use. They include serums, vaccines, antitoxins, blood, antigens and blo...
REGULATORY REQUIREMENTS FOR DRUG PRODUCTS REGISTRATION IN SOUTH AFRICA
The South African Pharmaceutical market is one of the emerging markets in the world and it is important to study on how to register a drug in the promising pharmaceutical market in Africa. The MCC is the regulatory body...
AN OVERVIEW ABOUT NOVEL FAST DISSOLVING ORAL FILMS
Nowadays, novel fast dissolving oral films (FDF) have come in existence as an alternative dosage form in comparison with tablet, capsules, syrup and other oral dosage forms with respect to patient convenience and complia...
TRIPS AND INDIAN PHARMACEUTICAL INDUSTRY
The TRIPs Agreement has led to a reinforcement of the protection of intellectual property, particularly in many developing countries. From the point of view of transfer of technology, the imitation of technologies from i...